Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Hollebecque A, Salvagni S, Plummer R, Niccoli P, et al. Cancer 2022;128:3185-3195.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hollebecque A, Salvagni S, Plummer R, Niccoli P, et al. Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Cancer 2022;128:3185-3195.
PMID: 35737639